Osiris Therapeutics Inc. isn't making any promises that it will meet the latest deadline handed down by the Nasdaq Stock Exchange to get current with its financial reporting. A Nasdaq Stock Exchange hearings panel has decided to give the Columbia biotech until March 10 to become current with its financial filings with the U.S.
Comment on Osiris Therapeutics could be delisted from Nasdaq in March
Holden Wilen, Biz Journals
Mon, 12/05/2016 - 8:42am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more